Affi­ni-T to close Seat­tle lab as it con­cen­trates in Boston, preps two IND fil­ings in next two months

Affi­ni-T Ther­a­peu­tics is clos­ing its Seat­tle site at the end of Au­gust, CEO and co-founder Jak Knowles con­firmed to End­points News Wednes­day af­ter­noon.

The biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER